NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Rezolute
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
Ricoh USA, Inc.
Fudan University
HRYZ Biotech Co.
Eastern Cooperative Oncology Group
Washington University School of Medicine
OHSU Knight Cancer Institute
Canadian Cancer Trials Group
European Organisation for Research and Treatment of Cancer - EORTC
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
OHSU Knight Cancer Institute
Sheffield Teaching Hospitals NHS Foundation Trust
Maria Sklodowska-Curie National Research Institute of Oncology
Maria Sklodowska-Curie National Research Institute of Oncology
Celgene
N.N. Petrov National Medical Research Center of Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
University of Miami
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
University of South Florida
European Organisation for Research and Treatment of Cancer - EORTC
Oncolytics Biotech
Children's Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)